Literature DB >> 22391923

Primary amebic meningoencephalitis: a case report and literature review.

Christina Lopez1, Phillip Budge, Jimmy Chen, Suzanne Bilyeu, Ayesha Mirza, Haidee Custodio, Jose Irazuzta, Govinda Visvesvara, Kevin J Sullivan.   

Abstract

Primary amebic meningoencephalitis (PAM) is a rare but nearly always fatal disease caused by infection with Naegleria fowleri, a thermophilic, free-living ameba found in freshwater environments. Cases of N. fowleri infection have been reported from many of the southern-tier states in the United States, with Florida and Texas disproportionately represented among them. Primary amebic meningoencephalitis presents clinically in a fashion that may be indistinguishable from bacterial and viral meningitis. Unfortunately, because the disease is so rare, PAM is often excluded from the differential diagnosis of children with meningitis resulting in delayed diagnostic and therapeutic efforts.Pediatric acute care practitioners in emergency departments, general pediatric wards, and critical care units, especially those practicing in the southern United States, should be familiar with the risk factors for acquisition of PAM, its clinical presentation, and the fact that common empiric treatment of bacterial meningitis will not treat N. fowleri. Herein, we present the case of an adolescent who died of PAM and review the (a) epidemiology, (b) pathophysiology, (c) available diagnostic modalities, (d) treatment options, and (e) outcomes of patients treated for N. fowleri infection of the central nervous system.

Entities:  

Mesh:

Year:  2012        PMID: 22391923     DOI: 10.1097/PEC.0b013e3182495589

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  8 in total

1.  Comparison of the clinical presentations of Naegleria fowleri primary amoebic meningoencephalitis with pneumococcal meningitis: a case-control study.

Authors:  Mohammad Faizan Zahid; Muhammad Hamza Saad Shaukat; Bilal Ahmed; Mohammad Asim Beg; Muhammad Masood Kadir; Syed Faisal Mahmood
Journal:  Infection       Date:  2016-02-27       Impact factor: 3.553

2.  Association of CPAP bacterial colonization with chronic rhinosinusitis.

Authors:  Christopher J Chin; Charles George; Robert Lannigan; Brian W Rotenberg
Journal:  J Clin Sleep Med       Date:  2013-08-15       Impact factor: 4.062

3.  A Fatal Case of Primary Amoebic Meningoencephalitis from Recreational Waters.

Authors:  Edward Hamaty; Saif Faiek; Minesh Nandi; David Stidd; Manish Trivedi; Hari Kandukuri
Journal:  Case Rep Crit Care       Date:  2020-05-28

4.  In Vitro Activity of Statins against Naegleria fowleri.

Authors:  Aitor Rizo-Liendo; Ines Sifaoui; María Reyes-Batlle; Olfa Chiboub; Rubén L Rodríguez-Expósito; Carlos J Bethencourt-Estrella; Desirée San Nicolás-Hernández; Edyta B Hendiger; Atteneri López-Arencibia; Pedro Rocha-Cabrera; José E Piñero; Jacob Lorenzo-Morales
Journal:  Pathogens       Date:  2019-08-08

5.  Case Report and Literature Review: Bacterial Meningoencephalitis or Not? Naegleria fowleri Related Primary Amoebic Meningoencephalitis in China.

Authors:  Wenjuan Zhou; Yuzhen Ouyang; Di Zhang; Sheng Liao; Hui Liang; Lingling Zhao; Chunyuan Chen
Journal:  Front Pediatr       Date:  2022-04-08       Impact factor: 3.569

6.  A case report: primary amoebic meningoencephalitis in a young Zambian adult.

Authors:  Mashina Chomba; Luchenga A Mucheleng'anga; Sombo Fwoloshi; Joseph Ngulube; Mable M Mutengo
Journal:  BMC Infect Dis       Date:  2017-08-01       Impact factor: 3.090

7.  Evaluation of Indolocarbazoles from Streptomyces sanyensis as a Novel Source of Therapeutic Agents against the Brain-Eating Amoeba Naegleria fowleri.

Authors:  Aitor Rizo-Liendo; Ines Sifaoui; Luis Cartuche; Iñigo Arberas-Jiménez; María Reyes-Batlle; José J Fernández; José E Piñero; Ana R Díaz-Marrero; Jacob Lorenzo-Morales
Journal:  Microorganisms       Date:  2020-05-25

8.  Laurinterol from Laurencia johnstonii eliminates Naegleria fowleri triggering PCD by inhibition of ATPases.

Authors:  Iñigo Arberas-Jiménez; Sara García-Davis; Aitor Rizo-Liendo; Ines Sifaoui; María Reyes-Batlle; Olfa Chiboub; Rubén L Rodríguez-Expósito; Ana R Díaz-Marrero; José E Piñero; José J Fernández; Jacob Lorenzo-Morales
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.